PRME - Prime Medicine - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

PRME is currently covered by 4 analysts with an average price target of $8. This is a potential upside of $4.45 (125.35%) from yesterday's end of day stock price of $3.55.

Prime Medicine's activity chart (see below) currently has 55 price targets and 54 ratings on display. The stock rating distribution of PRME is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 18.75% of the time, taking 48.33 days on average.

Highest price target for PRME is $11, Lowest price target is $6, average price target is $8.

Most recent stock forecast was given by ARTHUR HE from HC WAINWRIGHT. First documented stock forecast 14-Nov-2022.

Currently out of the existing stock ratings of PRME, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Aug-2026

$8

$4.45 (125.35%)

$8

6 days ago
(16-Nov-2026)

Buy Since 25-Aug-2026

$7

$3.45 (97.18%)

$7

1 months 28 days ago
(25-Sep-2026)

0/2 (0%)

$4.1 (141.38%)

Buy Since 10-Dec-2024

$6

$2.45 (69.01%)

$6

5 months ago
(22-Jun-2026)

2/6 (33.33%)

$2.63 (78.04%)

121

Buy Since 09-Oct-2023

$11

$7.45 (209.86%)

$10

8 months 10 days ago
(12-Mar-2026)

0/5 (0%)

$7.27 (194.91%)

Hold Since 11-Nov-2025

$4.25

1 years 11 days ago
(11-Nov-2025)

1/4 (25%)

$0.33 (8.42%)

29

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRME (Prime Medicine) average time for price targets to be met?

On average it took 48 days for the stock forecasts to be reached, with an average price target met ratio of 18.75%.

Which analyst most recently updated their price target on PRME (Prime Medicine)?

Arthur He

Which analyst has the most public recommendations on PRME (Prime Medicine)?

Arthur He has 13 price targets and 8 ratings on PRME

Which analyst is the currently most bullish on PRME (Prime Medicine)?

Matthew Harrison with the highest potential upside of $17.45

Which analyst is the currently most reserved on PRME (Prime Medicine)?

Eric Joseph with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?